SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001764013-24-000109
Filing Date
2024-05-29
Accepted
2024-05-29 16:36:00
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-K imvt-20240331.htm   iXBRL 10-K 1675687
2 EX-23.1 exhibit231-20240331.htm EX-23.1 6406
3 EX-31.1 exhibit311-20240331.htm EX-31.1 9441
4 EX-31.2 exhibit312-20240331.htm EX-31.2 9425
5 EX-32.1 exhibit321-20240331.htm EX-32.1 4759
6 EX-32.2 exhibit322-20240331.htm EX-32.2 4746
7 EX-97.1 exhibit971-20240331.htm EX-97.1 44537
13 GRAPHIC imvt-20240331_g1.jpg GRAPHIC 71399
14 GRAPHIC imvt-20240331_g2.jpg GRAPHIC 126502
15 GRAPHIC imvt-20240331_g3.jpg GRAPHIC 73723
16 GRAPHIC imvt-20240331_g4.jpg GRAPHIC 46872
17 GRAPHIC imvt-20240331_g5.jpg GRAPHIC 120289
18 GRAPHIC imvt-20240331_g6.jpg GRAPHIC 116872
19 GRAPHIC imvt-20240331_g7.jpg GRAPHIC 107073
20 GRAPHIC imvt-20240331_g8.jpg GRAPHIC 54584
  Complete submission text file 0001764013-24-000109.txt   8123463

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20240331.xsd EX-101.SCH 35432
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20240331_cal.xml EX-101.CAL 60761
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20240331_def.xml EX-101.DEF 213640
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20240331_lab.xml EX-101.LAB 555504
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20240331_pre.xml EX-101.PRE 387511
79 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20240331_htm.xml XML 536909
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-38906 | Film No.: 24999065
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)